Julie A. Wickenden

712 total citations
7 papers, 529 citations indexed

About

Julie A. Wickenden is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Julie A. Wickenden has authored 7 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Oncology and 1 paper in Pathology and Forensic Medicine. Recurrent topics in Julie A. Wickenden's work include Ubiquitin and proteasome pathways (2 papers), Glycosylation and Glycoproteins Research (1 paper) and Cell death mechanisms and regulation (1 paper). Julie A. Wickenden is often cited by papers focused on Ubiquitin and proteasome pathways (2 papers), Glycosylation and Glycoproteins Research (1 paper) and Cell death mechanisms and regulation (1 paper). Julie A. Wickenden collaborates with scholars based in United Kingdom and United States. Julie A. Wickenden's co-authors include Christine J. Watson, Kathryn Balmanno, Simon J. Cook, Katherine Hughes, Judith E. Allen, Rebecca Gilley, Ceri M. Wiggins, Eileen White, Kurt Degenhardt and Katherine Ewings and has published in prestigious journals such as The EMBO Journal, Oncogene and The Journal of Pathology.

In The Last Decade

Julie A. Wickenden

7 papers receiving 520 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julie A. Wickenden United Kingdom 6 341 173 93 71 68 7 529
Leslie Douglas United States 11 476 1.4× 176 1.0× 114 1.2× 97 1.4× 41 0.6× 13 589
Hexiao Wang China 10 346 1.0× 139 0.8× 69 0.7× 134 1.9× 56 0.8× 18 538
Cristina Bértolo Spain 11 229 0.7× 162 0.9× 192 2.1× 89 1.3× 81 1.2× 19 578
Di Xiang China 15 284 0.8× 132 0.8× 102 1.1× 101 1.4× 84 1.2× 27 559
Manon de Ladurantaye Canada 13 265 0.8× 156 0.9× 77 0.8× 129 1.8× 42 0.6× 17 574
Tanner J. Freeman United States 8 238 0.7× 136 0.8× 69 0.7× 95 1.3× 44 0.6× 13 446
Avijit Majumdar United States 11 445 1.3× 223 1.3× 65 0.7× 100 1.4× 31 0.5× 13 628
José Luis Linares France 4 318 0.9× 208 1.2× 183 2.0× 48 0.7× 70 1.0× 4 629
Xin Jing China 12 305 0.9× 173 1.0× 135 1.5× 106 1.5× 56 0.8× 28 554
Yanwen Zhou Japan 16 394 1.2× 158 0.9× 119 1.3× 90 1.3× 32 0.5× 34 618

Countries citing papers authored by Julie A. Wickenden

Since Specialization
Citations

This map shows the geographic impact of Julie A. Wickenden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie A. Wickenden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie A. Wickenden more than expected).

Fields of papers citing papers by Julie A. Wickenden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie A. Wickenden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie A. Wickenden. The network helps show where Julie A. Wickenden may publish in the future.

Co-authorship network of co-authors of Julie A. Wickenden

This figure shows the co-authorship network connecting the top 25 collaborators of Julie A. Wickenden. A scholar is included among the top collaborators of Julie A. Wickenden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie A. Wickenden. Julie A. Wickenden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Grassian, Alexandra, Sarah K. Knutson, Kevin W. Kuntz, et al.. (2015). A Medium-Throughput Single Cell CRISPR-Cas9 Assay to Assess Gene Essentiality. Biological Procedures Online. 17(1). 15–15. 5 indexed citations
2.
Hammond, Dean E., et al.. (2015). Differential Reprogramming of Isogenic Colorectal Cancer Cells by Distinct Activating KRAS Mutations. Journal of Proteome Research. 14(3). 1535–1546. 63 indexed citations
3.
Hughes, Katherine, Julie A. Wickenden, Judith E. Allen, & Christine J. Watson. (2011). Conditional deletion of Stat3 in mammary epithelium impairs the acute phase response and modulates immune cell numbers during post‐lactational regression. The Journal of Pathology. 227(1). 106–117. 81 indexed citations
4.
Wickenden, Julie A. & Christine J. Watson. (2010). Key signalling nodes in mammary gland development and cancer. Signalling downstream of PI3 kinase in mammary epithelium: a play in 3 Akts. Breast Cancer Research. 12(2). 202–202. 69 indexed citations
5.
Wickenden, Julie A., Mark Johnson, Mark Austin, et al.. (2008). Colorectal cancer cells with the BRAFV600E mutation are addicted to the ERK1/2 pathway for growth factor-independent survival and repression of BIM. Oncogene. 27(57). 7150–7161. 59 indexed citations
6.
Ewings, Katherine, Ceri M. Wiggins, Julie A. Wickenden, et al.. (2007). ERK1/2‐dependent phosphorylation of BimEL promotes its rapid dissociation from Mcl‐1 and Bcl‐xL. The EMBO Journal. 26(12). 2856–2867. 145 indexed citations
7.
Wickenden, Julie A., Murray C.H. Clarke, Adriano G. Rossi, et al.. (2003). Cigarette Smoke Prevents Apoptosis through Inhibition of Caspase Activation and Induces Necrosis. American Journal of Respiratory Cell and Molecular Biology. 29(5). 562–570. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026